Form 4: Guardant Health CFO Michael Bell Reports Stock Transactions

Guardant Health's Chief Financial Officer, Michael Bell, reported the acquisition and disposal of company stock and restricted stock units on December 15, 2024.

Summary

• Michael Bell, the Chief Financial Officer of Guardant Health, reported several transactions involving the company's stock on December 15, 2024.
• These transactions include the acquisition of 1,233 and 2,039 shares of common stock through the vesting of restricted stock units.
• Additionally, 1,659 shares were disposed of to cover tax withholding obligations related to the vesting of restricted stock units at a price of $34.76 per share.
• Following these transactions, Mr. Bell directly owns 25,688 shares of common stock.
• Mr. Bell also holds 6,165 and 12,234 restricted stock units.

Sentiment

Score: 6

Explanation: The document reflects routine transactions related to executive compensation. There is no indication of positive or negative sentiment, it is a neutral event.

Positives

• The vesting of restricted stock units indicates that performance milestones were likely met.
• The acquisition of shares through vesting increases Mr. Bell's stake in the company.

Negatives

• The disposal of 1,659 shares, while for tax purposes, slightly reduces Mr. Bell's direct holdings.

Risks

• The sale of shares to cover tax obligations could be perceived negatively by some investors, although it is a common practice.
• Changes in executive holdings can sometimes be a signal of internal sentiment, although in this case it is a routine transaction.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

• The vesting schedule of the restricted stock units is typical for executive compensation packages in the biotech industry.
• The tax withholding process is standard practice for equity compensation.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation.

Key Dates

Keywords

Guardant Health, Michael Bell, stock transactions, restricted stock units, Form 4, insider trading, executive compensation, vesting